MGLIX
Price
$16.46
Change
-$0.04 (-0.24%)
Updated
Dec 17 closing price
RRGRX
Price
$7.20
Change
-$0.02 (-0.28%)
Updated
Dec 17 closing price
Ad is loading...

MGLIX vs RRGRX

Header iconMGLIX vs RRGRX Comparison
Open Charts MGLIX vs RRGRXBanner chart's image
MFS Global Real Estate I
Price$16.46
Change-$0.04 (-0.24%)
VolumeN/A
CapitalizationN/A
DWS RREEF Global Real Estate Secc R6
Price$7.20
Change-$0.02 (-0.28%)
VolumeN/A
CapitalizationN/A
MGLIX vs RRGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLIX vs. RRGRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLIX is a Sell and RRGRX is a Hold.

FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.32B vs. RRGRX (156M). MGLIX pays higher dividends than RRGRX: MGLIX (1.87) vs RRGRX (1.47). MGLIX was incepted earlier than RRGRX: MGLIX (16 years) vs RRGRX (8 years). RRGRX is a more actively managed with annual turnover of: 82.00 vs. MGLIX (30.00). MGLIX (0) and RRGRX (0) have matching initial minimum investment requirements. RRGRX annual gain was more profitable for investors over the last year : 7.83 vs. MGLIX (1.37). MGLIX return over 5 years is better than : 3.66 vs. RRGRX (-4.10).
MGLIXRRGRXMGLIX / RRGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years8 years-
Gain YTD-0.3085.985-5%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.32B156M1,485%
Annual Yield % from dividends1.871.47127%
Returns for 1 year1.377.8317%
Returns for 3 years-19.65-13.92141%
Returns for 5 years3.66-4.10-89%
Returns for 10 years30.94N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.41-0.33
-0.74%
UDR
CRESY13.58-0.21
-1.52%
Cresud S.A.C.I.F. y A.
CMND1.27-0.04
-3.05%
Clearmind Medicine
OI10.69-0.46
-4.13%
O-I Glass
APLT1.10-0.05
-4.35%
Applied Therapeutics